Functional Imaging with (18)F-FDG PET/CT and Diffusion Weighted Imaging (DWI) in Early Response Evaluation of Combination Therapy of Elotuzumab, Lenalidomide, and Dexamethasone in a Relapsed Multiple Myeloma Patient

Elotuzumab is the first monoclonal antibody approved for the treatment of relapsed-refractory multiple myeloma (MM) in combination with lenalidomide, an immunodulatory drug, and dexamethasone. We report on a multiply pre-treated MM patient with disease progression due to appearance of new focal lesi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Diagnostics (Basel)
Hoofdauteurs: Sachpekidis, Christos, Dimitrakopoulou-Strauss, Antonia, Delorme, Stefan, Goldschmidt, Hartmut
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI 2017
Onderwerpen:
Interesting Images
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5745397/
https://ncbi.nlm.nih.gov/pubmed/29244720
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics7040061
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items